Janssen Products, LP
Horsham, PA Doing business as Ortho Biotech Products, LP Part of Janssen Biotech Inc.
- UEI
- Z1TQMKVX5MD4
- CAGE
- 44H50
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Janssen Biotech Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Janssen Biotech Inc. · Horsham, PA
NVYMGFA53MN7
-
Parent
Janssen Biotech Inc. · Horsham, PA
NVYMGFA53MN7
- SAM.gov registration date
- Physical address
- 800 Ridgeview Drive, Horsham, PA 19044, USA
- Website
- jnj.com
- Founded
- 1886
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $22,685 |
| FY2025 | $0 |
| FY2024 | $136,113 |
| FY2023 | $158,798 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $22,685 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Ferring Pharmaceuticals Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Actelion Pharmaceuticals US, Inc. | Hopewell Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Centocor Ortho Biotech Inc. | Horsham, PA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Janssen Pharmaceuticals, Inc. | Hopewell Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Solco Healthcare US LLC | Franklin Township, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Janssen Products, LP, doing business as Ortho Biotech Products, LP, is a for-profit pharmaceutical manufacturer and subsidiary of Johnson & Johnson registered with the federal government since September 2005. The company supplies critical medications to federal healthcare agencies, particularly the Department of Veterans Affairs, and maintains its principal place of business in Horsham, Pennsylvania. Janssen has established itself as a reliable provider of specialty pharmaceuticals to support federal healthcare missions, with a demonstrated track record of fulfilling urgent and routine pharmaceutical procurement needs across multiple government networks and facilities.
Janssen Products, LP has provided pharmaceutical products exclusively to the Department of Veterans Affairs through its Veterans Integrated Service Networks via delivery orders issued against existing federal supply schedule contracts. The company's primary product supplied through federal contracts has been Sirturo (bedaquiline), an antitubercular medication indicated for the treatment of multidrug-resistant tuberculosis in veteran populations. Since 2022, Janssen has received numerous delivery orders valued at $22,685.43 each from Veterans Integrated Service Network 21, with additional orders from Veterans Integrated Service Network 23, all issued under firm fixed price arrangements and without set-aside designations. These delivery orders have been placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance completed at Janssen's Horsham, Pennsylvania facility. The delivery orders have ranged from one-month to two-month performance periods, with ultimate completion dates spanning from December 2022 through February 2026. Notably, all awards have been executed as prime contracts with no identified subcontractors or team arrangements, reflecting Janssen's direct supply relationship with the Veterans Affairs healthcare system.
Janssen Products, LP currently holds two significant federal contract indefinite delivery vehicles under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The first is a multiple-award Federal Supply Schedule contract awarded on September 29, 2025, with a ceiling value of $468 million and an ultimate completion date of September 28, 2030, which enables Veterans Integrated Service Networks to procure drugs, pharmaceuticals, and hematology-related products at pre-negotiated firm fixed prices in compliance with 2026 Public Law pricing requirements. The second is a single-award Blanket Purchase Agreement valued at $1,474,552.95, awarded on November 25, 2025, with a completion date of November 24, 2026, specifically focused on Sirturo (bedaquiline) procurement to streamline task order issuance without requiring individual competitive procurements. Both vehicles are managed under General Services Administration auspices and funded through the National Acquisition Center and Veterans Integrated Service Networks. These indefinite delivery vehicles are designed to allow multiple Veterans Integrated Service Networks to place task orders for specialized pharmaceutical products, with typical delivery orders ranging from $15,000 to $68,000, ensuring cost-effective and efficient access to critical medications for veteran populations across the nation.
Quick answers
Is Janssen Products, LP registered in SAM.gov?
Yes. Janssen Products, LP's SAM.gov registration is active through November 17, 2026.
Which contract vehicles does Janssen Products, LP hold?
Janssen Products, LP holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Janssen Products, LP received in federal contracts?
Federal contracts obligated $317,596 to Janssen Products, LP in fiscal years 2023 through 2027.
How does Janssen Products, LP rank among federal contractors?
Janssen Products, LP's parent company, Janssen Biotech Inc., ranked #46 in PSC Q517, #58 in NAICS 325412 and #91 in NAICS 3254 in FY2025.
What is Janssen Products, LP's most recent federal award?
Janssen Products, LP's most recent federal contract award is Emergency pharmauctuical - bedaquiline 100MG (36C26126N0271), from Veterans Integrated Service Network 21 (VHA), on January 2, 2026.
On GovTribe
See Janssen Products, LP's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors